Andres Gutiérrez

Andres A. Gutiérrez currently works at Old Ayala, Inc., as Chief Medical Officer from 2023 and Biosight Therapeutics, Inc., as Chief Medical Officer from 2018.
Dr. Gutiérrez also formerly worked at Bristol Myers Squibb Co., as Medical Director-Early Development Immuno-Oncology from 2012 to 2015, BioMarin Pharmaceutical, Inc., as Medical Director, Sonoma Pharmaceuticals, Inc., as Medical Director, Sunesis Pharmaceuticals, Inc., as Medical Director, Proteolix, Inc., as Medical Director, Instituto Nacional de Salud Pública de México, as Director-Gene & Cell Therapy Unit, Instituto Nacional de Ciencias Medicas y Nutricion, as Director-Gene & Cell Therapy Unit, Oncolytics Biotech, Inc., as Chief Medical Officer from 2016 to 2018, Advaxis, Inc., as Chief Medical Officer & Executive Vice President, Sellas Life Sciences Group Ltd., as Chief Medical Officer from 2015 to 2016, Instil Bio, Inc., as Chief Medical Officer in 2025, and Ayala Pharmaceuticals, Inc., as Chief Medical Officer & Executive Vice President from 2018 to 2024.
Dr. Gutiérrez received his doctorate degree from Universidad Nacional Autónoma de México.